Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00609726 · ClinicalTrials.gov registry record
Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 199
- Enrollment target
NCT00609726: Completed study, sponsored by University of Alabama at Birmingham.
NCT00609726 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 199 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00609726 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 199 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the best evaluation for patients with idiopathic (unexplained) pancreatitis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 2015-12 |
| Est. Completion | 2015-12 |
What the finished NCT00609726 record still lists
NCT00609726 is an observational study that tracks outcomes without assigning an intervention. The registered 199 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00609726 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00609726 about?
NCT00609726 is a clinical study titled "Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography". The purpose of the study is to determine the best evaluation for patients with idiopathic (unexplained) pancreatitis.
What is the current status of trial NCT00609726?
This trial is currently completed. The enrollment target is 199 participants. The study started on 2015-12. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT00609726?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04312126 · 199 participants
The Beneficial Effects of Naps on Motor Learning
- NCT04951622 · 199 participants · Phase 3
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- NCT06474533 · 199 participants
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia